Portal de Periódicos da CAPES

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes

2009; Oxford University Press; Volume: 160; Issue: 2 Linguagem: Inglês

10.1111/j.1365-2249.2009.04082.x

1365-2249

Silvia Marín-Gallén, Xavier Clemente‐Casares, Raquel Planas, Irma Pujol‐Autonell, Jorge Carrascal, Jorge Carrillo, Rosa María Ampudia, Joan Verdaguer, Ricardo Pujol‐Borrell, Francesc E. Borràs, Marta Vives‐Pi,

Immune Cell Function and Interaction

Summary Dendritic cells (DCs) are powerful antigen-presenting cells capable of maintaining peripheral tolerance. The possibility to generate tolerogenic DCs opens new therapeutic approaches in the prevention or remission of autoimmunity. There is currently no treatment inducing long-term tolerance and remission in type 1 diabetes (T1D), a disease caused by autoimmunity towards β cells. An ideal immunotherapy should inhibit the autoimmune attack, avoid systemic side effects and allow islet regeneration. Apoptotic cells – a source of autoantigens – are cleared rapidly by macrophages and DCs through an immunologically silent process that contributes to maintaining tolerance. Our aims were to prevent T1D and to evaluate the re-establishment of peripheral tolerance using autologous DCs pulsed in vitro with apoptotic bodies from β cells. Immature DCs derived from bone marrow of non-obese diabetic (NOD) mice were obtained and pulsed with antigen-specific apoptotic bodies from the β cell line NIT-1. Those DCs that phagocytosed apoptotic cells diminished the expression of co-stimulatory molecules CD40 and CD86 and reduced secretion of proinflammatory cytokines. Moreover, these cells were resistant to increase the expression of co-stimulatory molecules after lipopolysaccharide activation. The administration of these cells to NOD transgenic mice expressing interferon-β in their insulin-producing cells, a model of accelerated autoimmune diabetes, decreased diabetes incidence significantly and correlated positively with insulitis reduction. DCs pulsed with apoptotic cells that express disease-associated antigens constitutes a promising strategy to prevent T1D.